Genetic Variants in RASSF1 (rs2073498), SERPINE1 (rs1799889), and EFNA1 (rs12904) Are Associated with Susceptibility in Mexican Patients with Colorectal Cancer: Clinical Associations and Their Analysis In Silico
Authors:
- César de Jesús Tovar-JácomeCTCésar de Jesús Tovar-Jácome
- Clara Ibet Juárez-VázquezCJClara Ibet Juárez-Vázquez
- Martha Patricia Gallegos-ArreolaMartha Patricia Gallegos-Arreola
- José Elías García-OrtizJGJosé Elías García-Ortiz
- María Eugenia Marín-ContrerasMMMaría Eugenia Marín-Contreras
- Tomás Daniel Pineda-RazoTPTomás Daniel Pineda-Razo
- Ignacio Mariscal-RamírezIMIgnacio Mariscal-Ramírez
- Oscar Durán-AnguianoODOscar Durán-Anguiano
- Aldo Antonio Alcaraz-WongAAAldo Antonio Alcaraz-Wong
- Rubria Alicia González-SánchezRGRubria Alicia González-Sánchez
- Marina Lizbeth Mundaca-RodríguezMMMarina Lizbeth Mundaca-Rodríguez
- Miriam Yadira Godínez-RodríguezMGMiriam Yadira Godínez-Rodríguez
Open Access
Abstract
Background/Objectives: Colorectal cancer (CRC) is the second leading cause of cancer death worldwide. Variants in genes that regulate processes such as apoptosis and angiogenesis play a significant role in CRC. The objective of this study is to investigate the possible association between RASSF1 (rs2073498), SERPINE1 (rs1799889), EFNA1 (rs12904), and RAD51 (rs1801320) variants and clinicopathological characteristics of Mexican patients with CRC. Methods: DNA of peripheral blood samples was obtained from 631 individuals (349 patients and 282 control individuals). The RASSF1 (rs2073498), SERPINE1 (rs1799889), EFNA1 (rs12904), and RAD51 (rs1801320) variants were genotyped by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). The association was calculated using the odds ratio (OR) test. p-values were adjusted by the Bonferroni test (0.0125). In silico analysis programs, including Combined Annotation Dependent Depletion (CADD), Polymorphism Phenotyping-2 (PolyPhen-2), and Gene Expression Profiling Interactive Analysis (GEPIA), were conducted to predict the functional impact of these variants. Results: Patients carrying the G/A genotype of the RASSF1 (rs2073498) variant showed an association with CRC characteristics, including TNM stages and tumor location (OR > 2.5, p = 0.001). Regarding the SERPINE1 (rs1799889) variant, patients carrying the 5G/4G genotype showed an association between TNM stages and tumor location in the rectum (OR > 1.5, p ≤ 0.05). Patients with the G/G genotype for the EFNA1 (rs12904) variant showed an association with TNM stages and rectal tumor location (OR > 2.0, p = 0.001). The RAD51 (rs1801320) variant had no association with colorectal cancer. Conclusions: RASSF1 (rs2073498), SERPINE1 (rs1799889), and EFNA1 (rs12904) variants significantly influence colorectal cancer risk.Keywords
Funding Information
- Instituto Mexicano del Seguro Social (IMSS)
This publication has 74 references indexed in Scilit:
- The effect of healthy eating on the development of stomach and colorectal cancer by the smoking and drinking status: Results from the Korean National Cancer Center (KNCC) community cohort studyCancer Medicine, 2024
- Association of Epidermal Growth Factor 61A>G, Survivin-31G>C, and EFNA1-1732G>A Polymorphisms with Susceptibility to Colorectal CancerJournal of Gastrointestinal Cancer, 2022
- Investigation of the relationship between CTLA4 and the tumor suppressor RASSF1A and the possible mediating role of STAT4 in a cohort of Egyptian patients infected with hepatitis C virus with and without hepatocellular carcinomaArchives of Virology, 2021
- MicroRNA‐binding site polymorphisms and risk of colorectal cancer: A systematic review and meta‐analysisCancer Medicine, 2019
- The role of the miR‐200 family in epithelial–mesenchymal transition in colorectal cancer: a systematic reviewInternational Journal of Cancer, 2018
- MicroRNAs, TGF-β signaling, and the inflammatory microenvironment in cancerTumor Biology, 2015
- Colorectal cancer and RASSF family—A special emphasis on RASSF1AInternational Journal of Cancer, 2012
- Lack of association between plasminogen activator inhibitor type-1 (PAI-1) gene 4G/5G polymorphism and osteoarthritisRheumatology International, 2011
- Polymorphisms in RAD51, XRCC2 and XRCC3 genes of the homologous recombination repair in colorectal cancer—a case control studyMolecular Biology Reports, 2010
- SERPINE1 intron polymorphisms affecting gene expression are associated with diffuse‐type gastric cancer susceptibilityCancer, 2010